Innovex International Inc. (INVX) Stock Falls on Q4 2025 Earnings

Innovex International Inc. (INVX) reported fourth-quarter 2025 results.

Revenue: $273.6 million (+9.1% year-over-year).

Cost of goods sold: $194.5 million (+17.3% year-over-year), pressuring margins.

Gross profit: $79.1 million (-6.8% year-over-year).

Operating profit: $25.8 million (-3.6% year-over-year).

Balance sheet and cash flow highlights

Net cash and equivalents: $203.4 million (up 177.6% year-over-year).

Cash from operating activities: $52.2 million (up 43.7% year-over-year).

Capital expenditures: $8.9 million (up 17.0% year-over-year).

Total liabilities: $210.6 million (down 12.0% year-over-year).

Earnings per share and market reaction

Diluted earnings per share: $0.20, down sharply year-over-year.

Analyst estimate for EPS: $0.33.

Stock moved -4.31% since market close.

Summary: Revenues grew mid-single digits, but rising cost of sales and lower gross profit led to a steep decline in net income despite positive operating cash flow. The company strengthened its cash position significantly and trimmed liabilities, while capital spending increased modestly.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

Innovex International Inc. Insider Trading Activity

Innovex International Inc. insiders have traded $INVX stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $INVX stock by insiders over the last 6 months:

MARK REDDOUT (President of North America) sold 20,000 shares for an estimated $500,000
ADAM ANDERSON (Chief Executive Officer) sold 13,241 shares for an estimated $331,025

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Innovex International Inc. Hedge Fund Activity

We have seen 97 institutional investors add shares of Innovex International Inc. stock to their portfolio, and 97 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

MADISON AVENUE PARTNERS, LP removed 1,767,997 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $32,778,664
SG AMERICAS SECURITIES, LLC added 580,795 shares (+inf%) to their portfolio in Q4 2025, for an estimated $12,701,986
VICTORY CAPITAL MANAGEMENT INC added 570,014 shares (+628.3%) to their portfolio in Q4 2025, for an estimated $12,466,206
PACER ADVISORS, INC. removed 388,523 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $8,496,998
WELLINGTON MANAGEMENT GROUP LLP removed 375,340 shares (-15.4%) from their portfolio in Q4 2025, for an estimated $8,208,685
AVIDIAN WEALTH ENTERPRISES, LLC added 266,162 shares (+inf%) to their portfolio in Q4 2025, for an estimated $5,820,962
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 261,597 shares (-73.2%) from their portfolio in Q4 2025, for an estimated $5,721,126

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Innovex International Inc. Congressional Stock Trading

Members of Congress have traded $INVX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $INVX stock by members of Congress over the last 6 months:

REPRESENTATIVE DEBBIE WASSERMAN SCHULTZ sold up to $0 on 11/25.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Innovex International Inc. Analyst Ratings

Wall Street analysts have issued reports on $INVX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Piper Sandler issued a "Overweight" rating on 12/18/2025

To track analyst ratings and price targets for Innovex International Inc., check out Quiver Quantitative's $INVX forecast page.

Innovex International Inc. Price Targets

Multiple analysts have issued price targets for $INVX recently. We have seen 2 analysts offer price targets for $INVX in the last 6 months, with a median target of $23.5.

Here are some recent targets:

Derek Podhaizer from Piper Sandler set a target price of $27.0 on 12/18/2025
Eddie Kim from Barclays set a target price of $20.0 on 11/14/2025